2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine
|
|
|
- CAS-Nr.
- 161599-46-8
- Englisch Name:
- 2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine
- Synonyma:
- DFCR;Capecitabine Impurity M;Capecitabine Impurity D;InterMediate of Capecitabine;uorocytidine;Capecitabine-2;-5'-deoxy-5-fL;2',3'-Di-O-acetyL;Capecitabine Imp.D;Capecitabine USP IMp.D
- CBNumber:
- CB81090886
- Summenformel:
- C13H16FN3O6
- Molgewicht:
- 329.28
- MOL-Datei:
- 161599-46-8.mol
|
2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine Eigenschaften
- Schmelzpunkt:
- 196-198?C
- Siedepunkt:
- 427.4±55.0 °C(Predicted)
- Dichte
- 1.57±0.1 g/cm3(Predicted)
- storage temp.
- Keep in dark place,Sealed in dry,2-8°C
- L?slichkeit
- soluble in Methanol
- Aggregatzustand
- powder to crystal
- pka
- 2.49±0.10(Predicted)
- Farbe
- White to Almost white
- InChI
- InChI=1S/C13H16FN3O6/c1-5-9(22-6(2)18)10(23-7(3)19)12(21-5)17-4-8(14)11(15)16-13(17)20/h4-5,9-10,12H,1-3H3,(H2,15,16,20)/t5-,9-,10-,12-/m1/s1
- InChIKey
- NWJBWNIUGNXJGO-YHHSPFQVSA-N
- SMILES
- C[C@H]1O[C@@H](N2C=C(F)C(N)=NC2=O)[C@H](OC(=O)C)[C@@H]1OC(=O)C
- CAS Datenbank
- 161599-46-8(CAS DataBase Reference)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| S-S?tze: |
24/25 |
|
|
| HS Code |
29389090 |
|
|
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H302 |
Gesundheitssch?dlich bei Verschlucken. |
Akute Toxizit?t oral |
Kategorie 4 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P270, P301+P312, P330, P501 |
| H315 |
Verursacht Hautreizungen. |
Hautreizung |
Kategorie 2 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P302+P352, P321,P332+P313, P362 |
| H319 |
Verursacht schwere Augenreizung. |
Schwere Augenreizung |
Kategorie 2 |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
P264, P280, P305+P351+P338,P337+P313P |
| H335 |
Kann die Atemwege reizen. |
Spezifische Zielorgan-Toxizit?t (einmalige Exposition) |
Kategorie 3 (Atemwegsreizung) |
Warnung |
![GHS hazard pictograms]() src="/GHS07.jpg" width="20" height="20" /> |
|
|
| Sicherheit |
| P261 |
Einatmen von Staub vermeiden. |
| P305+P351+P338 |
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen. |
|
2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White to Off-White Solid
Definition
ChEBI: A member of the class of cytidines that is a metabolite of the drug capecitabine.
2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 494)Lieferanten
161599-46-8()Verwandte Suche:
- (2R,3R,4R,5R)-2-(4-aMino-5-fluoro-2-oxopyriMidin-1(2H)-yl)-5-Methyltetrahydrofuran-3,4-diyl diacetate
- 2',3'-di-O-acetyl-5'-deoxy-5-fulurocytidine
- 2,3-diACETATE 5,DEOXY 5,FLUORO CYTIDINE
- Cytidine,5'-deoxy-5-fluoro-, 2',3'-diacetate
- Capecitabine USP IMp.D
- 2',3'-Di-O-carbonyl-5'-deoxy-5-fluorocytidine
- 2 ', 3'-di-O-acetyl -5' - deoxy -5-- fluoro-D-cell pyridine
- 5'-deoxy - diacetyl -5-- fluoro cytidine
- 2',3'-Di-O-acetyl-5'-deoxy-5-fluoro-D-cytidine
- 2,3-DI-O-ACETYL-5-DEOXY-5-FULURO-D-CYTIDINE
- 2',3'-DI-O-ACETYL-5'-DEOXY-5-FLUOROCYTIDIN
- Capecitabine Diacetyl Amino Impurity
- 2',3'-Di-O-acetyl-5'-deoxy-5-fulurocytdine
- 2',3'-Di-o-acetyl-5-fluoro cytidine
- (2R,3R,4S,5R)-2-(4-Amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-5-methyltetrahydrofuran-3,4-diyl di
- 5'-Deoxy-2',3'-di-O-acetyl-5-fluorocytidine
- (2R,3R,4S,5R)-4-(acetyloxy)-2-(4-aMino-5-fluoro-2-oxo-1,2-dihydropyriMidin-1-yl)-5-Methyloxolan-3-yl acetate
- 2',3'-Diacetoxyl-5'-deoxy-5-flurocytidine
- 5'-Deoxy-5-fluoro-cytidine 2',3'-Diacetate
- Capecitabine Impurity C (EP )
- Capecitabine Impurity 13(Capecitabine EP Impurity C)
- Capecitabine EP Impurity C
- Capecitabine-2
- Capecitabine impurity 4/Capecitabine EP Impurity C/Capecitabine Diacetyl Amino Impurity (USP)/2’,3’-Di-O-acetyl-5’-deoxy-5-fluorocytidine
- [(2R,3R,4R,5R)-4-acetoxy-5-(4-amino-5-fluoro-2-oxo-pyrimidin-1-yl)-2-methyl-tetrahydrofuran-3-yl] acetate
- Capecitabine Diacetyl Amino Imp
- 2',3'-Di-O-acetyl-5'-deoxy-5-F-Cytidine
- 3'-di-O-acetyl-5'-deoxy-5-fulurocytidine
- Capecitabin iMpurity D
- Capecitabine Impurity M(Capecitabine EP Impurity C)
- Capecitabine Imp.D
- 2',3'-Di-O-acetyL
- uorocytidine
- 2,3-Di-O-acetyl-5-deoxy-5-fluoro-D-cytidine [CAP5]
- 2',3'-Di-O-acetyl-5'-deoxy-5-flouro-D-cytidine
- -5'-deoxy-5-fL
- 2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine USP/EP/BP
- InterMediate of Capecitabine
- Capecitabine Impurity M
- Capecitabine Impurity D
- DFCR
- (2R,3R,4R,5R)-2-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-2-fluoro-5-methyltetrahydrofuran-3,4-diyl diacetate
- Cytidine, 5'-deoxy-5-fluoro-, 2',3'-diacetate (9CI, ACI)
- 5'-deoxy-5-fluoro-Cytidine 2',3'-diacetate (9CI ACI)
- 2'',3''DiOacetyl5''deoxy5fuluroDcytidine,2'',3'' Di O acetyl 5'' deoxy 5 fuluro D cytidine
- 2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine
- 5’-Deoxy-5-fluorocytidine 2’,3’-Diacetate
- 2',3'-Di-O-acetyl-5'-deoxy-5-fluorocytidine
- 2'',3''-Di-O-acetyl-5''-deoxy-5-fuluro-D-cytidine
- Cytidine, 5'-deoxy-5-fluoro-, 2',3'-diacetate
- 1-(2,3-Di-O-acetyl-5-deoxy-beta-D-ribofuranosyl)-4-amino-5-fluoropyrimidin-2(1H)-one
- 2'''',3''''-Di-O-acetyl-5''''-deoxy-5-fuluro-D-cytidine
- 2'''',3''''-Di-O-acetyl-5''''-deoxy-5-fuluro-D-cytidine, 10 mM in DMSO
- 161599-46-8
- 161500-46-8
- C13H18FN3O6
- Intermediates
- Bases & Related Reagents
